Henneberg, Lukas T. http://orcid.org/0000-0003-3477-4541
Singh, Jaspal
Duda, David M.
Baek, Kheewoong http://orcid.org/0000-0002-6853-4936
Yanishevski, David
Murray, Peter J. http://orcid.org/0000-0001-6329-9802
Mann, Matthias http://orcid.org/0000-0003-1292-4799
Sidhu, Sachdev S. http://orcid.org/0000-0001-7755-5918
Schulman, Brenda A. http://orcid.org/0000-0002-3083-1126
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (Nedd8Activate - 789016)
Deutsche Forschungsgemeinschaft (SCHU3196)
Max-Planck-Gesellschaft
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA021765)
Gouvernement du Canada | Canadian Institutes of Health Research (MOP-93684)
Article History
Received: 26 January 2023
Accepted: 29 June 2023
First Online: 31 August 2023
Competing interests
: B.A.S. is a member of Interline Therapeutics and BioTheryX SABs. The remaining authors declare no conflicts of interest.